These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 31171904)
41. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359 [TBL] [Abstract][Full Text] [Related]
42. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells. Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917 [TBL] [Abstract][Full Text] [Related]
43. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
44. Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition. Yuan X; Piao L; Wang L; Han X; Tong L; Shao S; Xu X; Zhuang M; Liu Z Aging (Albany NY); 2020 Dec; 13(2):1947-1961. PubMed ID: 33323539 [TBL] [Abstract][Full Text] [Related]
45. Epithelial-mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model. Veloso ES; de Carvalho BA; de Souza Silva FH; Ribeiro TS; Lima BM; Almeida CP; da Silva VHSR; Rocha SA; de Araújo Campos MR; Del Puerto HL; Ferreira E Sci Rep; 2022 Oct; 12(1):17776. PubMed ID: 36273071 [TBL] [Abstract][Full Text] [Related]
46. Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway. Lee AY; Fan CC; Chen YA; Cheng CW; Sung YJ; Hsu CP; Kao TY Integr Cancer Ther; 2015 Sep; 14(5):484-90. PubMed ID: 26036622 [TBL] [Abstract][Full Text] [Related]
47. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672 [TBL] [Abstract][Full Text] [Related]
48. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635 [TBL] [Abstract][Full Text] [Related]
49. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869 [TBL] [Abstract][Full Text] [Related]
50. Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells. Li R; Zhao Y; Chen J; Shao S; Zhang X Mol Med Rep; 2014 Feb; 9(2):413-8. PubMed ID: 24297333 [TBL] [Abstract][Full Text] [Related]
51. IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process. Le Coz V; Zhu C; Devocelle A; Vazquez A; Boucheix C; Azzi S; Gallerne C; Eid P; Lecourt S; Giron-Michel J Oncotarget; 2016 Dec; 7(50):82511-82527. PubMed ID: 27764776 [TBL] [Abstract][Full Text] [Related]
52. S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma. Zhang M; Zheng S; Jing C; Zhang J; Shen H; Xu X; Lin J; Zhang B Future Oncol; 2018 Apr; 14(9):837-847. PubMed ID: 29569474 [TBL] [Abstract][Full Text] [Related]
53. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. Zhou P; Qin J; Li Y; Li G; Wang Y; Zhang N; Chen P; Li C J Exp Clin Cancer Res; 2017 Sep; 36(1):115. PubMed ID: 28865485 [TBL] [Abstract][Full Text] [Related]
54. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition. Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563 [TBL] [Abstract][Full Text] [Related]
55. Steroid Receptor RNA Activator, a Long Noncoding RNA, Activates p38, Facilitates Epithelial-Mesenchymal Transformation, and Mediates Experimental Melanoma Metastasis. Hong CH; Ho JC; Lee CH J Invest Dermatol; 2020 Jul; 140(7):1355-1363.e1. PubMed ID: 31945347 [TBL] [Abstract][Full Text] [Related]
56. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway. Ping H; Guo L; Xi J; Wang D Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497 [TBL] [Abstract][Full Text] [Related]
57. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition. Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942 [TBL] [Abstract][Full Text] [Related]
58. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway. Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726 [TBL] [Abstract][Full Text] [Related]
59. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα. Xin H; Wang C; Liu Z BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631 [TBL] [Abstract][Full Text] [Related]
60. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma. Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]